Pasar al contenido principal

EVALUACION DEL POTENCIAL VACUNAL DE RECEPTORES ABC PARA EL DESARROLLO DE NUEVAS VACUNAS CONTRA STREPTOCOCCUS SUIS (ABC-VACCINESS)

PID2020-114617RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

How Streptococcus suis escapes antibiotic treatments

  • Uruén, Cristina
  • García, Carla
  • Fraile Sauce, Lorenzo José
  • Tommassen, Jan
  • Arenas, Jesús
Streptococcus suis is a zoonotic agent that causes sepsis and meningitis in pigs and humans. S. suis infections are responsible for large economic losses in pig production. The lack of effective vaccines to prevent the disease has promoted the extensive use of antibiotics worldwide. This has been followed by the emergence of resistance against different classes of antibiotics. The rates of resistance to tetracyclines, lincosamides, and macrolides are extremely high, and resistance has spread worldwide. The genetic origin of S. suis resistance is multiple and includes the production of target-modifying and antibiotic-inactivating enzymes and mutations in antibiotic targets. S. suis genomes contain traits of horizontal gene transfer. Many mobile genetic elements carry a variety of genes that confer resistance to antibiotics as well as genes for autonomous DNA transfer and, thus, S. suis can rapidly acquire multiresistance. In addition, S. suis forms microcolonies on host tissues, which are associations of microorganisms that generate tolerance to antibiotics through a variety of mechanisms and favor the exchange of genetic material. Thus, alternatives to currently used antibiotics are highly demanded. A deep understanding of the mechanisms by which S. suis becomes resistant or tolerant to antibiotics may help to develop novel molecules or combinations of antimicrobials to fight these infections. Meanwhile, phage therapy and vaccination are promising alternative strategies, which could alleviate disease pressure and, thereby, antibiotic use., This work received funding from Gobierno de Aragón (Department of Science, University and Knowledge Society) for the development of I+D+i projects in priority lines (Grant agreement LMP58_21) and from Ministerio de Ciencia e Innovación/Agencia Española de Investigacion MCIN/ AEI/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe”, by the “European Union” or by the “European Union NextGenerationEU/PRTR¨ (Grant agreement PID2020-114617RB-I00).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Invasive Streptococcus suis isolated in Spain contain a highly promiscuous and dynamic resistome

  • Uruén, Cristina
  • Gimeno, Jorge
  • Sanz, Marina
  • Fraile Sauce, Lorenzo José
  • Marín, Clara M.
  • Arenas, Jesús
Introduction: Streptococcus suis is a major pathogen for swine and human. Here we aimed to know the rates of antimicrobial resistance (AMR) in invasive S. suis isolates recovered along Spain between 2016 – 2021 and elucidate their genetic origin. Methods: Antibiotic susceptibility testing was performed for 116 isolates of different genetic backgrounds and geographic origins against 18 antibiotics of 9 families. The association between AMR and genotypes and the origin of the isolates were statistically analyzed using Pearson´s chi-square test and the likelihood ratio. The antimicrobial resistant genes were identified by whole genome sequencing analysis and PCR screenings. Results: High AMR rates (>80%) were detected for tetracyclines, spectinomycin, lincosamides, and marbofloxacin, medium (20-40%) for sulphonamides/trimethoprim, tiamulin, penicillin G, and enrofloxacin, and low (< 20%) for florfenicol, and four additional β-lactams. The occurrence of multidrug resistance was observed in 90% of isolates. For certain antibiotics (penicillin G, enrofloxacin, marbofloxacin, tilmicosin, and erythromycin), AMR was significantly associated with particular sequence types (STs), geographic regions, age of pigs, and time course. Whole genome sequencing comparisons and PCR screenings identified 23 AMR genes, of which 19 were previously reported in S. suis (aph(3’)-IIIa, sat4, aadE, spw, aac(6’)-Ie-aph(2’’)-Ia, fexA, optrA, erm(B), mef(A/E), mrs(D), mph(C), lnu(B), lsa(E), vga(F), tet(M), tet(O), tet(O/W/32/O), tet(W)), and 4 were novel (aph(2’’)-IIIa, apmA, erm(47), tet(T)). These AMR genes explained the AMR to spectinomycin, macrolides, lincosamides, tiamulin, and tetracyclines. Several genes were located on mobile genetic elements which showed a variable organization and composition. As AMR gene homologs were identified in many human and animal pathogens, the resistome of S. suis has a different phylogenetic origin. Moreover, AMR to penicillin G, fluoroquinolones, and trimethoprim related to mutations in genes coding for target enzymes (pbp1a, pbp2b, pbp2x, mraY, gyrA, parC, and dhfr). Bioinformatic analysis estimated traits of recombination on target genes, also indicative of gene transfer events. Conclusions: Our work evidences that S. suis is a major contributor to AMR dissemination across veterinary and human pathogens. Therefore, control of AMR in S. suis should be considered from a One Health approach in regions with high pig production to properly tackle the issue of antimicrobial drug resistance., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work received funding from Gobierno de Aragón (Department of I+D+I projects in priority lines, Grant agreement LMP58_21), and Ministerio de Ciencia e Innovación/Agencia Española de Investigación MCIN/AEI/10.13039/501100011033, as appropriate, by ERDF A way of making Europe by the European Union or by the European Union NextGenerationEU/PRTR (Gran agreement PID2020-114617RB-100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Invasive Streptococcus suis isolated in Spain contain a highly promiscuous and dynamic resistome

  • Uruén, Cristina
  • Gimeno, Jorge
  • Sanz, Marina
  • Fraile Sauce, Lorenzo José
  • Marín, Clara M.
  • Arenas, Jesús
Introduction: Streptococcus suis is a major pathogen for swine and human. Here we aimed to know the rates of antimicrobial resistance (AMR) in invasive S. suis isolates recovered along Spain between 2016 – 2021 and elucidate their genetic origin. Methods: Antibiotic susceptibility testing was performed for 116 isolates of different genetic backgrounds and geographic origins against 18 antibiotics of 9 families. The association between AMR and genotypes and the origin of the isolates were statistically analyzed using Pearson´s chi-square test and the likelihood ratio. The antimicrobial resistant genes were identified by whole genome sequencing analysis and PCR screenings. Results: High AMR rates (>80%) were detected for tetracyclines, spectinomycin, lincosamides, and marbofloxacin, medium (20-40%) for sulphonamides/trimethoprim, tiamulin, penicillin G, and enrofloxacin, and low (< 20%) for florfenicol, and four additional β-lactams. The occurrence of multidrug resistance was observed in 90% of isolates. For certain antibiotics (penicillin G, enrofloxacin, marbofloxacin, tilmicosin, and erythromycin), AMR was significantly associated with particular sequence types (STs), geographic regions, age of pigs, and time course. Whole genome sequencing comparisons and PCR screenings identified 23 AMR genes, of which 19 were previously reported in S. suis (aph(3’)-IIIa, sat4, aadE, spw, aac(6’)-Ie-aph(2’’)-Ia, fexA, optrA, erm(B), mef(A/E), mrs(D), mph(C), lnu(B), lsa(E), vga(F), tet(M), tet(O), tet(O/W/32/O), tet(W)), and 4 were novel (aph(2’’)-IIIa, apmA, erm(47), tet(T)). These AMR genes explained the AMR to spectinomycin, macrolides, lincosamides, tiamulin, and tetracyclines. Several genes were located on mobile genetic elements which showed a variable organization and composition. As AMR gene homologs were identified in many human and animal pathogens, the resistome of S. suis has a different phylogenetic origin. Moreover, AMR to penicillin G, fluoroquinolones, and trimethoprim related to mutations in genes coding for target enzymes (pbp1a, pbp2b, pbp2x, mraY, gyrA, parC, and dhfr). Bioinformatic analysis estimated traits of recombination on target genes, also indicative of gene transfer events. Conclusions: Our work evidences that S. suis is a major contributor to AMR dissemination across veterinary and human pathogens. Therefore, control of AMR in S. suis should be considered from a One Health approach in regions with high pig production to properly tackle the issue of antimicrobial drug resistance., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work received funding from Gobierno de Aragón (Department of I+D+I projects in priority lines, Grant agreement LMP58_21), and Ministerio de Ciencia e Innovación/Agencia Española de Investigación MCIN/AEI/10.13039/501100011033, as appropriate, by ERDF A way of making Europe by the European Union or by the European Union NextGenerationEU/PRTR (Gran agreement PID2020-114617RB-100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

How Streptococcus suis escapes antibiotic treatments

  • Uruén, Cristina
  • García, Carla
  • Fraile Sauce, Lorenzo José
  • Tommassen, Jan
  • Arenas, Jesús
Streptococcus suis is a zoonotic agent that causes sepsis and meningitis in pigs and humans. S. suis infections are responsible for large economic losses in pig production. The lack of effective vaccines to prevent the disease has promoted the extensive use of antibiotics worldwide. This has been followed by the emergence of resistance against different classes of antibiotics. The rates of resistance to tetracyclines, lincosamides, and macrolides are extremely high, and resistance has spread worldwide. The genetic origin of S. suis resistance is multiple and includes the production of target-modifying and antibiotic-inactivating enzymes and mutations in antibiotic targets. S. suis genomes contain traits of horizontal gene transfer. Many mobile genetic elements carry a variety of genes that confer resistance to antibiotics as well as genes for autonomous DNA transfer and, thus, S. suis can rapidly acquire multiresistance. In addition, S. suis forms microcolonies on host tissues, which are associations of microorganisms that generate tolerance to antibiotics through a variety of mechanisms and favor the exchange of genetic material. Thus, alternatives to currently used antibiotics are highly demanded. A deep understanding of the mechanisms by which S. suis becomes resistant or tolerant to antibiotics may help to develop novel molecules or combinations of antimicrobials to fight these infections. Meanwhile, phage therapy and vaccination are promising alternative strategies, which could alleviate disease pressure and, thereby, antibiotic use., This work received funding from Gobierno de Aragón (Department of Science, University and Knowledge Society) for the development of I+D+i projects in priority lines (Grant agreement LMP58_21) and from Ministerio de Ciencia e Innovación/Agencia Española de Investigacion MCIN/ AEI/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe”, by the “European Union” or by the “European Union NextGenerationEU/PRTR¨ (Grant agreement PID2020-114617RB-I00).
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Genomic and phenotypic analysis of invasive Streptococcus suis isolated in Spain reveals genetic diversification and associated virulence traits

  • Uruén, Cristina
  • Fernandez, Ana
  • Arnal, José Luis
  • Del Pozo, Mateo
  • Amoribieta, Maria Casas
  • De Blas, Ignacio
  • Jurado, Paula
  • Calvo, Jorge Hugo
  • Gottschalk, Marcelo
  • González Vázquez, Luis Daniel
  • Arenas Busto, Miguel
  • Marín, Clara M.
  • Arenas Busto, Jesús
Streptococcus suis is a zoonotic pathogen that causes a major health problem in the pig production industry worldwide. Spain is one of the largest pig producers in the world. This work aimed to investigate the genetic and phenotypic features of invasive S. suis isolates recovered in Spain. A panel of 156 clinical isolates recovered from 13 Autonomous Communities, representing the major pig producers, were analysed. MLST and serotyping analysis revealed that most isolates (61.6%) were assigned to ST1 (26.3%), ST123 (18.6%), ST29 (9.6%), and ST3 (7.1%). Interestingly, 34 new STs were identified, indicating the emergence of novel genetic lineages. Serotypes 9 (27.6%) and 1 (21.8%) prevailed, followed by serotypes 7 (12.8%) and 2 (12.2%). Analysis of 13 virulence-associated genes showed significant associations between ST, serotype, virulence patterns, and clinical features, evidencing particular virulence traits associated with genetic clusters. The pangenome was generated, and the core genome was distributed in 7 Bayesian groups where each group included a variable set of over- and under-represented genes of different categories. The study provides comprehensive data and knowledge to improve the design of new vaccines, antimicrobial treatments, and bacterial typing approaches., Agencia Estatal de Investigación | Ref. PID2020-114617RB-I00, Gobierno de Aragón | Ref. LMP58_21, Universidad de Zaragoza | Ref. UZ2020-BIO-01
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Clinically relevant genomic and phenotypic differences in virulence, antimicrobial resistance, and biofilm-associated tolerance between Streptococcus suis lineages ST1 and ST123

  • Uruén, Cristina
  • Marín, Clara M.
  • González Vázquez, Luis Daniel
  • Gottschalk, Marcelo
  • Arenas Busto, Miguel
  • Arenas, Jesús
Streptococcus suis is a Gram-positive bacterium and an important pathogen in pigs and humans. It can be classified into more than 3000 sequence types (STs), among which the ST1 and ST123 lineages are highly prevalent in Spain. ST1 is a globally distributed lineage, while ST123 has emerged within the last decade only in Spain. In this study, we compared the genotypic and phenotypic characteristics of representative isolates from both lineages to better understand the factors driving the emergence of ST123. Comparative genomic analysis revealed higher genetic vari‑ ability in ST123 than in ST1. The genomes of both lineages share approximately 1429 genes, representing about 61% of the total genome. Among the lineage-specific genes, we identified 131–143 genes encoding proteins involved in diverse biological functions, including metabolism, regulation, transport, and virulence. Some of these genes were located on genetic islands, encoding for proteins involved in nutrition and catabolism of specific carbohydrates. In mouse infection models, both STs showed a strong capacity to cause systemic infection, although they differed in tis‑ sue persistence patterns. In macrophage cultures, ST123 isolates showed reduced adherence and intracellular survival compared with ST1. In contrast, ST123 isolates demonstrated the capacity to acquire ampicillin resistance under labo‑ ratory conditions. Moreover, ST123 isolates exhibited increased biofilm formation and enhanced tolerance to β-lactam antibiotics within biofilms compared with ST1. In conclusion, the combination of virulence, increased biofilm-associ‑ ated antibiotic tolerance, and increased propensity to acquire antimicrobial resistance may explain the rising preva‑ lence of ST123 in Spain. Its recent detection in Italy further supports its potential for expansion and establishment across Europe in the coming years., Agencia Estatal de Investigación | Ref. PID2020-114617RB-I00, Agencia Estatal de Investigación | Ref. PID2023–146823OB-I00, Agencia Estatal de Investigación | Ref. PID2023-151032NB-C22, Xunta de Galicia | Ref. ED481A 2023/089